Aural Analytics Launches A2E for Speech Collection and Analytics
Aural Analytics, a speech neuroscience and speech analytics technology company, has launched A2E, a mobile application software development kit and Web API for speech collection and cloud-based analytics across clinical research, health applications, and for in-clinic and remote settings.
The healthcare community continues to recognize the power of speech analysis for use in the identification and tracking of neurological and respiratory diseases and other conditions. Aural Analytics' A2E system enables speech collection and analytics via embeddable short, simple speech tasks. It also has configurable modules covering motor, cognitive, and respiratory diseases such as Parkinsons, ALS, alzheimers, stroke, COPD, migraine, schizophrenia and other diseases. The system is currently available in 14 languages and complies with the Health Information Portabililty and Accountability Act (HIPAA) and General Data Protection Regulation (GDPR).
"Speech collection and analytics are highly complex and require very specific expertise," said Dr. Jim Gemmell, Aural Analytics' chief technology officer, in a statement. "Our extensive experience in speech neuroscience and product development enables us to deliver embedded, ubiquitous speech collection and analytics through A2E across the continuum of care and lifespan. This system is incredibly easy to implement, works across languages, devices and use-cases, and is safe and secure, all while bringing about a seamless user experience that our integration partners can be proud of."
The A2E technology is based on nearly 30 years of speech neuroscience research, and includes a mobile application SDK with cloud-based computation that powers disease-specific speech tasks and analytics for use in clinical trials, telemedicine, remote monitoring and consumer applications. A2E is currently available for integration into iOS, android and web-based applications, with modules available for neurology and respiratory disease.